TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmore Consulting AB
Closing information (x1000 NOK)
Closing information | 2024/12 | 2023/12 | 2022/12 |
Turnover |
3,448
|
2,391 | |
Financial expenses |
1
|
2 | |
Earnings before taxes |
731
|
436 | |
EBITDA |
731
|
397 | |
Total assets |
978
|
635 | |
Current assets |
907
|
568 | |
Current liabilities |
303
|
192 | |
Equity capital |
675
|
443 | |
- share capital |
101
|
95 | |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Solvency |
69.0%
|
69.8% | |
Turnover per employee |
1,724
|
1,196 | |
Profit as a percentage of turnover |
21.2%
|
18.2% | |
Return on assets (ROA) |
74.8%
|
69.0% | |
Current ratio |
299.3%
|
295.8% | |
Return on equity (ROE) |
108.3%
|
98.4% | |
Change turnover |
887
|
368 | |
Change turnover % |
4%
|
35%
|
18% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.